Olav Mella

4.2k total citations · 1 hit paper
84 papers, 2.6k citations indexed

About

Olav Mella is a scholar working on Psychiatry and Mental health, Biomedical Engineering and Neurology. According to data from OpenAlex, Olav Mella has authored 84 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 25 papers in Biomedical Engineering and 15 papers in Neurology. Recurrent topics in Olav Mella's work include Fibromyalgia and Chronic Fatigue Syndrome Research (23 papers), Ultrasound and Hyperthermia Applications (20 papers) and Lymphoma Diagnosis and Treatment (8 papers). Olav Mella is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (23 papers), Ultrasound and Hyperthermia Applications (20 papers) and Lymphoma Diagnosis and Treatment (8 papers). Olav Mella collaborates with scholars based in Norway, United States and Germany. Olav Mella's co-authors include Olav Dahl, Øystein Fluge, Dionisio González, Jens Overgaard, Giorgio Arcangeli, Søren M. Bentzen, Maarten C.C.M. Hulshof, Ole Didrik Lærum, Ansgar Espeland and Ingfrid S. Haldorsen and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Olav Mella

78 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

1995 444 citations Jens Overgaard, Søren M. Bentzen et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olav Mella Norway	25	700	618	520	439	434	84	2.6k
Oliver Grauer Germany	31	470 0.7×	353 0.6×	421 0.8×	636 1.4×	751 1.7×	78	3.5k
Olav Dahl Norway	31	510 0.7×	391 0.6×	205 0.4×	705 1.6×	1.2k 2.9×	89	3.5k
Mark E. Shaffrey United States	36	556 0.8×	232 0.4×	1.2k 2.4×	549 1.3×	394 0.9×	144	5.2k
Masayuki Sasaki Japan	34	332 0.5×	238 0.4×	702 1.4×	438 1.0×	532 1.2×	165	3.7k
Joseph M. Piepmeier United States	30	548 0.8×	147 0.2×	559 1.1×	947 2.2×	274 0.6×	84	4.0k
Norihiko Tamaki Japan	34	227 0.3×	236 0.4×	1.9k 3.7×	635 1.4×	289 0.7×	249	4.7k
William C. Olivero United States	29	178 0.3×	155 0.3×	608 1.2×	549 1.3×	258 0.6×	77	2.4k
Maryam Rahman United States	34	468 0.7×	97 0.2×	731 1.4×	815 1.9×	938 2.2×	118	3.7k
Seunggu J. Han United States	39	237 0.3×	282 0.5×	1.1k 2.1×	473 1.1×	709 1.6×	117	4.7k
Andrea Salmaggi Italy	37	228 0.3×	460 0.7×	908 1.7×	1.3k 3.1×	1.2k 2.7×	253	5.8k

Countries citing papers authored by Olav Mella

Since Specialization

Citations

This map shows the geographic impact of Olav Mella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olav Mella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olav Mella more than expected).

Fields of papers citing papers by Olav Mella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olav Mella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olav Mella. The network helps show where Olav Mella may publish in the future.

Co-authorship network of co-authors of Olav Mella

This figure shows the co-authorship network connecting the top 25 collaborators of Olav Mella. A scholar is included among the top collaborators of Olav Mella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olav Mella. Olav Mella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sørland, Kari, et al.. (2023). Endothelial dysfunction in ME/CFS patients. PLoS ONE. 18(2). e0280942–e0280942. 19 indexed citations

Rekeland, Ingrid G., Kari Sørland, Ove Bruland, et al.. (2022). Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients. PLoS ONE. 17(9). e0274472–e0274472. 5 indexed citations

Hoel, Fredrik, Ina K. N. Pettersen, Ingrid G. Rekeland, et al.. (2021). A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 6(16). 34 indexed citations

Rekeland, Ingrid G., Elin Bolle Strand, Lisa E. Creary, et al.. (2021). Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. Brain Behavior and Immunity. 98. 101–109. 9 indexed citations

Rekeland, Ingrid G., Øystein Fluge, Kine Alme, et al.. (2018). Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome. Clinical Therapeutics. 41(5). 806–814. 3 indexed citations

Kristoffersen, Einar K., Dipak Sapkota, Kristin Risa, et al.. (2016). Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome. PLoS ONE. 11(8). e0161226–e0161226. 20 indexed citations

Fluge, Øystein, Kristin Risa, Kine Alme, et al.. (2015). B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS ONE. 10(7). e0129898–e0129898. 89 indexed citations

Fluge, Øystein, Ove Bruland, Kristin Risa, et al.. (2011). Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study. PLoS ONE. 6(10). e26358–e26358. 148 indexed citations

Schem, Baard‐Christian, et al.. (2009). cDNA Microarray Analysis of Serially Sampled Cervical Cancer Specimens From Patients Treated With Thermochemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 75(5). 1562–1569. 7 indexed citations

10.

Fluge, Øystein & Olav Mella. (2009). Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurology. 9(1). 28–28. 49 indexed citations

11.

Haldorsen, Ingfrid S., Ansgar Espeland, John Ludvig Larsen, & Olav Mella. (2005). Diagnostic delay in primary central nervous system lymphoma. Acta Oncologica. 44(7). 728–734. 56 indexed citations

12.

Risberg, Terje, Arne Kolstad, Erik A. Wist, et al.. (2003). [Should alternative therapists treat cancer--what is the opinion of oncology health personnel?].. PubMed. 123(21). 3059–61.

13.

Dahl, O. & Olav Mella. (2002). Referee: Hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. International Journal of Hyperthermia. 18(1). 25–30. 11 indexed citations

14.

Eikesdal, Hans Petter, et al.. (2001). Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors. Radiotherapy and Oncology. 60(2). 147–154. 30 indexed citations

15.

Pyrhönen, Seppo, Ritva Valavaara, Hans Modig, et al.. (1997). Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. British Journal of Cancer. 76(2). 270–277. 80 indexed citations

16.

Holte, Harald, Stein Kvaløy, Terje Engan, et al.. (1996). HOYDOSEBEHANDLING MED AUTOLOG STAMCELLESTOTTE VED MALIGNE LIDELSER. Tidsskrift for Den Norske Laegeforening. 116(21). 2577–2581. 1 indexed citations

17.

Overgaard, Jens, Søren M. Bentzen, Dionisio González, et al.. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet. 345(8949). 540–543. 444 indexed citations breakdown →

18.

Schem, Baard‐Christian, Olav Mella, & Olav Dahl. (1992). Thermochemotherapy with cisplatin or carboplatin in the BT4 rat glioma in vitro and in vivo. International Journal of Radiation Oncology*Biology*Physics. 23(1). 109–114. 11 indexed citations

19.

Wiedemann, G., Olav Mella, R.S. Coltart, Baard‐Christian Schem, & O. Dahl. (1988). Hyperthermia improves local tumour control in locally advanced breast cancer. Journal of Molecular Medicine. 66(20). 1034–1038. 6 indexed citations

20.

Dahl, O., et al.. (1987). Clinical hyperthermia combined with drugs and radiation. A phase I/II study.. PubMed. 163(7). 446–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact